These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 36748473)

  • 21. Preliminary Results of National Amyotrophic Lateral Sclerosis (ALS) Registry Risk Factor Survey Data.
    Bryan L; Kaye W; Antao V; Mehta P; Muravov O; Horton DK
    PLoS One; 2016; 11(4):e0153683. PubMed ID: 27124833
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Amyotrophic Lateral Sclerosis Descriptive Epidemiology: The Origin of Geographic Difference.
    Logroscino G; Piccininni M
    Neuroepidemiology; 2019; 52(1-2):93-103. PubMed ID: 30602169
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cost of disorders of the brain in Europe 2010.
    Gustavsson A; Svensson M; Jacobi F; Allgulander C; Alonso J; Beghi E; Dodel R; Ekman M; Faravelli C; Fratiglioni L; Gannon B; Jones DH; Jennum P; Jordanova A; Jönsson L; Karampampa K; Knapp M; Kobelt G; Kurth T; Lieb R; Linde M; Ljungcrantz C; Maercker A; Melin B; Moscarelli M; Musayev A; Norwood F; Preisig M; Pugliatti M; Rehm J; Salvador-Carulla L; Schlehofer B; Simon R; Steinhausen HC; Stovner LJ; Vallat JM; Van den Bergh P; van Os J; Vos P; Xu W; Wittchen HU; Jönsson B; Olesen J;
    Eur Neuropsychopharmacol; 2011 Oct; 21(10):718-79. PubMed ID: 21924589
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Economic burden of occupational injury and illness in the United States.
    Leigh JP
    Milbank Q; 2011 Dec; 89(4):728-72. PubMed ID: 22188353
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effectiveness of school-based family asthma educational programs on the quality of life and number of asthma exacerbations of children aged five to 18 years diagnosed with asthma: a systematic review protocol.
    Walter H; Sadeque-Iqbal F; Ulysse R; Castillo D; Fitzpatrick A; Singleton J
    JBI Database System Rev Implement Rep; 2015 Oct; 13(10):69-81. PubMed ID: 26571284
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Financial cost of amyotrophic lateral sclerosis: a case study.
    Obermann M; Lyon M
    Amyotroph Lateral Scler Frontotemporal Degener; 2015 Mar; 16(1-2):54-7. PubMed ID: 25245119
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Global epidemiology of amyotrophic lateral sclerosis: a systematic review of the published literature.
    Chiò A; Logroscino G; Traynor BJ; Collins J; Simeone JC; Goldstein LA; White LA
    Neuroepidemiology; 2013; 41(2):118-30. PubMed ID: 23860588
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
    Plosker GL; Figgitt DP
    Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
    [TBL] [Abstract][Full Text] [Related]  

  • 29. State and metropolitan area-based amyotrophic lateral sclerosis (ALS) surveillance.
    Wagner L; Rechtman L; Jordan H; Ritsick M; Sanchez M; Sorenson E; Kaye W
    Amyotroph Lateral Scler Frontotemporal Degener; 2015; 17(1-2):128-34. PubMed ID: 26399278
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence of Amyotrophic Lateral Sclerosis - United States, 2012-2013.
    Mehta P; Kaye W; Bryan L; Larson T; Copeland T; Wu J; Muravov O; Horton K
    MMWR Surveill Summ; 2016 Aug; 65(8):1-12. PubMed ID: 27490513
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The economic burden of vision loss and eye disorders among the United States population younger than 40 years.
    Wittenborn JS; Zhang X; Feagan CW; Crouse WL; Shrestha S; Kemper AR; Hoerger TJ; Saaddine JB;
    Ophthalmology; 2013 Sep; 120(9):1728-35. PubMed ID: 23631946
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Global variation in prevalence and incidence of amyotrophic lateral sclerosis: a systematic review and meta-analysis.
    Xu L; Liu T; Liu L; Yao X; Chen L; Fan D; Zhan S; Wang S
    J Neurol; 2020 Apr; 267(4):944-953. PubMed ID: 31797084
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A spatial analysis of amyotrophic lateral sclerosis (ALS) cases in the United States and their proximity to multidisciplinary ALS clinics, 2013.
    Horton DK; Graham S; Punjani R; Wilt G; Kaye W; Maginnis K; Webb L; Richman J; Bedlack R; Tessaro E; Mehta P
    Amyotroph Lateral Scler Frontotemporal Degener; 2018 Feb; 19(1-2):126-133. PubMed ID: 29262737
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The economic burden associated with stillbirth: A systematic review.
    Veettil SK; Kategeaw W; Hejazi A; Workalemahu T; Rothwell E; Silver RM; Chaiyakunapruk N
    Birth; 2023 Jun; 50(2):300-309. PubMed ID: 36774590
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Economic Impact of Originator-to-Biosimilar Non-medical Switching in the Real-World Setting: A Systematic Literature Review.
    Hillhouse E; Mathurin K; Bibeau J; Parison D; Rahal Y; Lachaine J; Beauchemin C
    Adv Ther; 2022 Jan; 39(1):455-487. PubMed ID: 34780028
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epidemiology of Amyotrophic Lateral Sclerosis in the Republic of Cyprus: A 25-Year Retrospective Study.
    Demetriou CA; Hadjivasiliou PM; Kleopa KA; Christou YP; Leonidou E; Kyriakides T; Zamba-Papanicolaou E
    Neuroepidemiology; 2017; 48(1-2):79-85. PubMed ID: 28528330
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epidemiological time-trend of amyotrophic lateral sclerosis (ALS) over two decades: The French population-based register of ALS in Limousin (FRALim register).
    Luna J; Defressigne O; Erazo D; Lautrette G; Raymondeau-Moustafa M; Preux PM; Boumediene F; Couratier P
    Rev Neurol (Paris); 2022 Nov; 178(9):914-923. PubMed ID: 36163089
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Can mortality data be used to estimate amyotrophic lateral sclerosis incidence?
    Marin B; Couratier P; Preux PM; Logroscino G
    Neuroepidemiology; 2011; 36(1):29-38. PubMed ID: 21088432
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The economic burden of low back pain in KwaZulu-Natal, South Africa: A prevalence-based cost-of-illness analysis from the healthcare provider's perspective.
    Kahere M; Ngcamphalala C; Östensson E; Ginindza T
    PLoS One; 2022; 17(10):e0263204. PubMed ID: 36227919
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.